Skip to main content

Advertisement

Log in

Mechanistic Implications of GSK and CREB Crosstalk in Ischemia Injury

  • Review
  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

Ischemia-reperfusion (IR) injury is a damage to an organ when the blood supply is less than the demand required for normal functioning, leading to exacerbation of cellular dysfunction and death. IR injury occurs in different organs like the kidney, liver, heart, brain, etc., and may not only involve the ischemic organ but also cause systemic damage to distant organs. Oxygen-glucose deprivation in cells causes oxidative stress, calcium overloading, inflammation, and apoptosis. CREB is an essential integrator of the body’s various physiological systems, and it is widely accepted that dysfunction of CREB signaling is involved in many diseases, including ischemia-reperfusion injury. The activation of CREB can provide life to a cell and increase the cell’s survival after ischemia. Hence, GSK/CREB signaling pathway can provide significant protection to cells of different organs after ischemia and emerges as a futuristic strategy for managing ischemia-reperfusion injury. Different signaling pathways such as MAPK/ERK, TLR4/MyD88, RISK, Nrf2, and NF-κB, get altered during IR injury by the modulation of GSK-3 and CREB (cyclic AMP response element (CRE)–binding protein). GSK-3 (protein kinase B) and CREB are the downstream targets for fulfilling the roles of various signaling pathways. Calcium overloading during ischemia increases the expression of calcium-calmodulin-dependent protein kinase (CaMK), which subsequently activates CREB-mediated transcription, thus promoting the survival of cells. Furthermore, this review highlights the crosstalk between GSK-3 and CREB, promoting survival and rendering the cells resistant to subsequent severe ischemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Availability of Data and Materials

Not applicable.

Abbreviations

IR injury:

Ischemia-reperfusion

CREB:

Cyclic AMP response element (CRE)-binding protein

GSK-3β:

Glycogen synthase kinase 3-β

CaMK:

Calcium-calmodulin-dependent protein kinase

ATP:

Adenosine triphosphate

PI3K:

Phosphoinositide-3-kinase

NF-κB:

Nuclear factor-kappa B

CBP:

CREB-binding protein

DM:

Diabetes mellitus

AD:

Alzheimer’s disease

cGAS:

Cyclic GMP-AMP synthase

STING:

Stimulator of interferon genes

GPCR:

G-protein-coupled receptors

RTK:

Receptor tyrosine kinase

NMDA:

N-methyl-D-aspartate

ROS:

Reactive oxygen species

TNF-α:

Tumor necrosis factor-α

IL-1β:

Interleukin-1β

NO:

Nitric oxide (NO)

TLR4:

Toll-like receptor

PKC:

Protein kinase C

PKA:

Protein kinase A

CaMK:

Ca2+/CaM-dependent kinase

HO-1:

Heme oxygenase 1

SOD:

Superoxide dismutase

TQ:

Thymoquinone

APNp:

Adiponectin peptide

DHPG:

Dihydroxyphenylglycine

BBR:

Berberine

CIG:

Cornel iridoid glycoside

BCCAO:

Bilateral common carotid artery occlusion

SCII:

Spinal cord ischemia-reperfusion injury

BDNF:

Brain-derived neurotrophic factor

DPP4:

Dipeptidyl peptidase4

CUR:

Curcumin

RISK:

Reperfusion injury salvage kinase

TDZD-8:

4-Benzyl-2-methyl-1,2,4-thiazolidine-3,5-dione

NMP:

Non-specific mitochondrial permeability

LMWF:

Low-molecular-weight fucoidan

KLF4:

Kruppel-like factor 4

PACAP-Pituitary:

adenylate cyclase-activating polypeptide

OLT:

Orthotopic liver transplantation

OA:

Oleanolic acid

LiCl:

Lithium chloride

AST:

Astaxanthin

DZ:

Daidzein

LDH:

Lactate dehydrogenase

MDA:

Malondialdehyde

FXR:

Farnesoid X receptor

References

Download references

Acknowledgements

The authors are grateful to the Chitkara College of Pharmacy, Chitkara University, Rajpura, Patiala, Punjab, India, for providing the necessary facilities to carry out the research work.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: Conceived- and designed the experiments: Thakur Gurjeet Singh. Analyzed the data: Amarjot Kaur. Wrote the manuscript: Heena Khan, Annu Bangar Visualization: Amarjot Kaur, Thakur Gurjeet Singh Editing of the Manuscript: Heena khan, Thakur Gurjeet Singh Critically reviewed the article: Thakur Gurjeet Singh Supervision: Thakur Gurjeet Singh.

Corresponding author

Correspondence to Thakur Gurjeet Singh.

Ethics declarations

Ethics Approval and Consent to Participate

Not applicable.

Consent to Participate

Not applicable.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khan, H., Bangar, A., Grewal, A.K. et al. Mechanistic Implications of GSK and CREB Crosstalk in Ischemia Injury. Neurotox Res 42, 1 (2024). https://doi.org/10.1007/s12640-023-00680-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12640-023-00680-1

Keywords

Navigation